Results 81 to 90 of about 3,738 (206)

Patient‐Reported Outcomes With Immediate‐Loaded Zygomatic Implant Fixed Rehabilitation in Patients With Edentulous Atrophic Maxilla: A Retrospective Practice‐Based Clinical Study

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objective To assess if immediate‐loaded zygomatic implant‐supported fixed rehabilitation meets the expectations of and satisfies patients with atrophic edentulous maxilla. Methods This study included an analysis of data obtained from the dental records of 22 consecutive patients with atrophic edentulous maxillae who received immediate‐loaded ...
Anisha Rodrigues, Samer Abi Nader, Nach Daniel, Elham Emami   +3 more
wiley   +1 more source

Considering the nocebo effect in the psychedelic discourse

Journal of Psychedelic Studies
This commentary addresses the potential for a nocebo effect arising from the public discourse on psychedelics, especially considering the increasing interest and engagement with these substances.
Maria Bălăeţ
semanticscholar   +1 more source

Fear of pain potentiates nocebo hyperalgesia

Journal of Pain Research, 2015
Per M Aslaksen,1 Peter S Lyby2 1Department of Psychology, Research Group for Cognitive Neuroscience, The Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway; 2Catosenteret Rehabilitation Center,
Aslaksen PM, Lyby PS
doaj  

Nocebo: The Power of Suggestibility

Preventive Medicine, 1997
A useful way to summarize the placebo-nocebo theme is to consider the tension and interaction between conviction and responsibility. With the conviction of the mainstream biomedical paradigm prevalent today, it would be tempting to say to Dr. Engel's patient: "That question is nonsense.
openaire   +3 more sources

Comparing Long‐Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Introduction Several studies have demonstrated that switching stable patients with inflammatory bowel disease (IBD) from originator to biosimilar infliximab is noninferior to continuing originator infliximab. However, “real‐world” data comparing long‐term outcomes between switch and nonswitch cohorts is lacking.
Paulina Suo, Ashish Srinivasan, Lena Thin, Yoon‐Kyo An, Richard G. Fernandes, Simon Ghaly, Angus W. Jeffrey, Shankar Menon, Nicholas Olsen, Thomas Skinner, Daniel R. van Langenberg, James Winston, Craig Haifer   +12 more
wiley   +1 more source

Understanding Placebo and Nocebo Responses Based on a Randomized Sham-Controlled Study on Acupuncture in Integrative Cancer Care

Integrative Cancer Therapies
Objective: Since placebo and nocebo-responses during acupuncture therapy are rarely studied in clinical contexts, the objective was to investigate placebo and nocebo-responses in a clinical context through comparing positive and negative side-effects ...
Anna Efverman
semanticscholar   +1 more source

Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses. [PDF]

PLoS ONE, 2014
A large number of unwanted adverse events and symptoms reported by patients in clinical trials are not caused by the drug provided, since most of adverse events also occur in corresponding placebo groups.
Laura Wendt, Antje Albring, Sven Benson, Harald Engler, Andrea Engler, Anke Hinney, Winfried Rief, Oliver Witzke, Manfred Schedlowski   +8 more
doaj   +1 more source

Managing Hypercholesterolemia in Adults Older Than 75 years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus From the National Lipid Association and the American Geriatrics Society

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT The risk of atherosclerotic cardiovascular disease increases with advancing age. Elevated LDL‐cholesterol and non‐HDL‐cholesterol levels remain predictive of incident atherosclerotic cardiovascular events among individuals older than 75 years.
Vera Bittner, Sunny A. Linnebur, Dave L. Dixon, Daniel E. Forman, Ariel R. Green, Terry A. Jacobson, Ariela R. Orkaby, Joseph J. Saseen, Salim S. Virani   +8 more
wiley   +1 more source

Nocebo belief and attitudes towards side effect disclosure: A general population-based online survey in Europe and North America.

European Journal of Pain
BACKGROUND With evidence for large nocebo effects in pain, guidelines for nocebo-minimizing strategies regarding side effect disclosure are emerging.
Mette Sieg, Kelly S. Clemens, Luana Colloca, Andrew L. Geers, L. Vase   +4 more
semanticscholar   +1 more source

Investigation of treatment continuity, usefulness, and nocebo effect in switching from original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.

Modern Rheumatology, 2023
OBJECTIVES To assess the usefulness and onset of nocebo effects after switching from original etanercept (ETN) to a biosimilar (BS) in routine clinical practice at rheumatology clinics in Japan (13 sites). METHODS A total of 165 patients (87.0% female,
T. Matsubara, K. Katayama, A. Sagawa, Masaaki Yoshida, T. Mitsuka, K. Hashimoto, T. Izumihara, M. Kondo, T. Izumiyama, N. Miyake, I. Yoshii, M. Oribe, S. Momohara, K. Funahashi   +13 more
semanticscholar   +1 more source